The Effect of IgM‐Enriched Human Ig and Rabbit Antithymocyte Globulin on the Stimulation of Mononuclear Cells

Whether IgM‐enriched intravenous Ig (pentaglobin) is a useful adjunct treatment for graft versus host disease (GvHD) prophylaxis in allogeneic stem‐cell transplantation is unclear. Clinical data with the use of a five‐agent GvHD prevention regimen, including pentaglobin and antithymocyte globulin (ATG), are encouraging. In vitro both have been reported to modulate alloreactive T cells. We compared their inhibitory effect on the phytohemagglutinin‐induced lymphocyte proliferation. ATG blocked the proliferation of lymphocytes at lower doses and much stronger than pentaglobin. The combination of both was not different from ATG alone. In pentaglobin, glucose used as stabiliser, caused the effect. Starting at a concentration of 40 mg/dL glucose, glucose alone showed a dose‐dependent inhibition of phytohemaglutinin (PHA)‐induced proliferation. For the in vivo application of pentaglobin, the results suggest that pentaglobin does not inhibit the proliferation of T cells.

[1]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[2]  N. Kröger,et al.  Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow , 1999, Bone Marrow Transplantation.

[3]  A. Zander,et al.  Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients , 1999, Bone Marrow Transplantation.

[4]  M. Daha,et al.  Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. , 1999, Blood.

[5]  M. Herold,et al.  Modulation of alloimmune response in vitro by an IgM‐enriched immunoglobulin preparation (Pentaglobin) , 1998, Immunology.

[6]  A. Smolyar,et al.  Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti‐TCR Fab fragment derived from a mitogenic antibody , 1998, The EMBO journal.

[7]  C. Huber,et al.  A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab′)2 fragments (5S IVIG) and Fc fragments. Evidence for post‐transcriptional IL‐2 modulation , 1997, Immunology.

[8]  G. Spickett,et al.  Contribution of Stabilizing Agents Present in Intravenous Immunoglobulin Preparations to Modulation of Mononuclear Cell Proliferation In Vitro , 1996, Scandinavian journal of immunology.

[9]  C. Fegan,et al.  Effect of IgM‐enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti‐endotoxin antibodies in bone marrow transplantation , 1993, European journal of clinical investigation.

[10]  C. Fegan,et al.  Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. , 1992, Bone marrow transplantation.

[11]  K. Sullivan,et al.  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.

[12]  D. Reece,et al.  Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host disease. , 1990, Bone marrow transplantation.

[13]  M. Barnett,et al.  Use of an immunoglobulin preparation enriched for IgA to treat recurrent sinopulmonary infections in a patient with chronic GVHD. , 1990, Bone marrow transplantation.

[14]  M. Kazatchkine,et al.  Anti‐idiotypes against Autoantibodies in Normal Immunoglobulins: Evidence for Network Regulation of Human Autoimmune Responses , 1989, Immunological reviews.

[15]  P. Cole,et al.  Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin. , 1989, Clinical and experimental immunology.

[16]  R. Kimberly,et al.  Modulation of mononuclear phagocyte function by intravenous gamma-globulin. , 1984, Journal of immunology.

[17]  J. Decker,et al.  Evidence that specific oligosaccharides block early events necessary for the expression of antigen-specific proliferation by human lymphocytes. , 1980, Journal of immunology.

[18]  S. Urbaniak,et al.  Phytohemagglutinin Transformation and Circulating Lymphocyte Subpopulations in Insulin-dependent Diabetic Patients , 1974, Diabetes.